Your email has been successfully added to our mailing list.

×
-0.00414937759336105 0 0 -0.00414937759336105 -0.00912863070539414 -0.00995850622406647 -0.00414937759336105 0.00165975103734436
Stock impact report

Amarin settles with Apotex, delays generic Vascepa until 2029 [Seeking Alpha]

Teva Pharmaceutical Industries Limited American Depositary Shares (TEVA) 
Last teva pharmaceutical industries limited american depositary shares earnings: 2/13 04:01 pm Check Earnings Report
US:NYSE Investor Relations: ir.tevapharm.com
Company Research Source: Seeking Alpha
Amarin (NASDAQ:AMRNpatent infringement disputeAmarin's appeal of anadverse patent rulingUnder the terms the the settlement agreement, Apotex may not sell its generic product until August 9, 2029 (the same date under a 2018 settlement agreement with Teva Pharmaceutical Industries) or earlier under certain circumstances (including if Amarin loses its appeal).Shares up5% Show less Read more
Impact Snapshot
Event Time:
TEVA
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
Last price at news event
Since Event
Multi-day stock performance from the time of the news release
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
Last Price
VWAP
High:
Max Up
High:
Low:
Max Down
Low:
%
Post news range
%
Price change

Price Change Percentage


S&P 500
(SPX)

%

Volume ratio
%

Volume
Ticks

Avg transaction size

Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Opt-in for TEVA alerts
Opt-in for
TEVA alerts

from News Quantified
Opt-in for
TEVA alerts

from News Quantified